April 2012 Drug Information Update - Pharmacy Benefits ...

More documents

Recommendations

Info

Metformin Oral Tablets March 30, 2012 Products Affected - Description Metformin tablets, Amneal 500 mg extended release, 90 count (NDC 53746-0178-90) - discontinued Metformin tablets, Glenmark 500 mg, 100 count (NDC 68462-0159-01) 500 mg, 1000 count (NDC 68462-0159-10) 850 mg, 90 count (NDC 68462-0160-90) 850 mg, 100 count (NDC 68462-0160-01) 1000 mg, 90 count (NDC 68462-0161-90) 1000 mg, 1000 count (NDC 68462-0161-10) Metformin tablets, Mutual Pharmaceuticals 500 mg, 100 count (NDC 53489-0467-01) - discontinued 500 mg, 500 count (NDC 53489-0467-05) - discontinued 500 mg, 1000 count (NDC 53489-0467-10) - discontinued 850 mg, 100 count (NDC 53489-0468-01) - discontinued 850 mg, 500 count (NDC 53489-0468-05) - discontinued 850 mg, 1000 count (NDC 53489-0468-10) - discontinued 1000 mg, 100 count (NDC 53489-0469-01) - discontinued 1000 mg, 500 count (NDC 53489-0469-05) - discontinued 1000 mg, 1000 count (NDC 53489-0469-10) - discontinued Metformin tablets, Mylan 500 mg, 100 count (NDC 00378-0234-01) 850 mg, 100 count (NDC 00378-0240-01) 750 mg extended release, 100 count (NDC 00378-0350-01) 500 mg, 500 count (NDC 00378-0234-05) - discontinued 500 mg extended release, 100 count (NDC 00378-0352-01) - discontinued 500 mg extended release, 500 count (NDC 00378-0352-05) - discontinued Metformin tablets, Ranbaxy 500 mg, 100 count (NDC 63304-0860-01) - discontinued 500 mg, 500 count (NDC 63304-0860-05) - discontinued 750 mg, 100 count (NDC 63304-0767-01) - discontinued Metformin tablets, Sandoz 850 mg, 12 x 60 package (NDC 00781-5051-61) Metformin tablets, Teva 500 mg, 100 count, unit dose (NDC 00093-1048-93) - discontinued 850 mg, 100 count, unit dose (NDC 00093-1049-93) - discontinued 1000 mg, 100 count, unit dose (NDC 00093-7214-93) - discontinued Metformin tablets, UDL 850 mg, 100 count, unit-dose (NDC 51079-0973-20) - discontinued 500 mg, 25 count, unit-dose (NDC 51079-0972-19) - discontinued 500 mg, 100 count, unit-dose (NDC 51079-0972-20) - discontinued 500 mg, 300 count, unit-dose (NDC 51079-0972-56) - discontinued Metformin tablets, Watson 850 mg, 1000 count (NDC 62037-0675-10) - discontinued 1000 mg, 1000 count (NDC 62037-0676-10) – discontinued Reason for the Shortage 76
• Apotex had metformin products unavailable due to an FDA import ban. Metformin immediaterelease tablets are not being currently marketed at this time. • Sandoz has metformin products on shortage due to manufacturing delays. • Ranbaxy has all discontinued metformin oral tablets. • Mutual discontinued all metformin products. • Teva discontinued metformin unit dose presentations in early-August, 2011. • UDL discontinued metformin 500 mg 100 unit dose presentation in late-July, 2011. • Watson discontinued metformin 850 mg and 1000 mg presentations. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=731 Source: www.ashp.org Lorazepam injectable presentations March 30, 2012 Products Affected - Description Lorazepam 2 mg/mL, Akorn 1 mL vial (NDC 17478-0040-01) Lorazepam 2 mg/mL, Bedford 1 mL vial (NDC 55390-0168-10) - discontinued 10 mL vial (NDC 55390-0170-10) - discontinued Lorazepam 4 mg/mL, Bedford 1 mL vial (NDC 53390-0169-10) - discontinued 10 mL vial (NDC 53390-0171-10) - discontinued Lorazepam 2 mg/mL, Hospira 1 mL iSecure prefilled syringes (NDC 00409-1985-05) - discontinued 1 mL Carpuject syringes (NDC 00409-1985-30) 1 mL vial (NDC 00409-6778-02) 10 mL vials (NDC 00409-6780-02) Lorazepam 4 mg/mL, Hospira 1 mL vial (NDC 00409-6779-02) 10 mL vial (NDC 00409-6781-02) 1 mL Carpuject syringes (NDC 00409-1539-31) Lorazepam 2 mg/mL, West-Ward 1 mL vial (NDC 10019-0102-01) 10 mL vial (NDC 10019-0102-10) 1 mL Novaplus vial (NDC 10019-0105-01) 10 mL Novaplus vial (NDC 10019-0105-02 ) Ativan 2 mg/mL, West-Ward 1 mL vial (NDC 60977-0112-01) 10 mL vial (NDC 60977-0116-02) Lorazepam 4 mg/mL, West-Ward 1 mL vial (NDC 10019-0103-01) 1 mL Novaplus vial (NDC 10019-0106-01) 10 mL vial (NDC 10019-0103-10) 10 mL Novaplus vial (NDC 10019-0106-02) Ativan 4 mg/mL, West-Ward 1 mL vial (NDC 60977-0113-01) 10 mL vial (NDC 60977-0113-02) Reason for the Shortage 77
Page 1 and 2:
April 2012 Drug Information Update
Page 3 and 4:
First-Time Generics GENERIC DRUG NA
Page 5 and 6:
GENERAL ANESTHETICS, INJECTABLE MID
Page 7 and 8:
Gruenhaupt, Mark R.Ph. Argus Health
Page 9 and 10:
Statin Drugs - Drug Safety Communic
Page 11 and 12:
Vytorin (ezetimibe/simvastatin) Tab
Page 13 and 14:
low blood sugar (hypoglycemia) in p
Page 15 and 16:
Some women with depression who beco
Page 17 and 18:
Survival increased for all groups o
Page 19 and 20:
finding that it also may reduce the
Page 21 and 22:
Syringes (2 mL size), Rx only. NDC
Page 23 and 24:
Patheon Pharmaceuticals Inc., Cinci
Page 25 and 26: 50-ct. bottles (NDC 0067-6238-50);
Page 27 and 28: PRODUCT (Class II) 1) Ventolin HFA
Page 29 and 30: Lot #: 0693, Exp: 10/2012 RECALLING
Page 31 and 32: 24 (Display case UPC# 3030045074923
Page 33 and 34: CODE Lot # 139961 RECALLING FIRM/MA
Page 35 and 36: Reason for the Shortage • Teva co
Page 37 and 38: Reason for the Shortage • Ben Ven
Page 39 and 40: Products Affected - Description Gan
Page 41 and 42: 37.5 mg/25 mg, 1000 count (NDC 0078
Page 43 and 44: Acyclovir tablets, Major 400 tablet
Page 45 and 46: 500 mg, 100 count (NDC 63304-0726-0
Page 47 and 48: 750 mg tablets, 100 count (NDC 1013
Page 49 and 50: • Bedford Laboratories has multip
Page 51 and 52: Daunorubicin Hydrochloride Injectio
Page 53 and 54: Ciprofloxacin Immediate-Release Tab
Page 55 and 56: • APP had tobramycin 40 mg/mL pre
Page 57 and 58: • Ben Venue voluntarily suspended
Page 59 and 60: 50 mg/mL, 10 mL vial, package of 10
Page 61 and 62: 2 mL vial, preservative-free (NDC 6
Page 63 and 64: 5 mg single dose vial, package of 1
Page 65 and 66: 20 mL glass ampule, sterile pack (N
Page 67 and 68: 2 mL iSecure syringe (NDC 00406-112
Page 69 and 70: Lidocaine 0.5% Xylocaine 0.5% injec
Page 71 and 72: • Teva discontinued all ciproflox
Page 73 and 74: Nicardipine hydrochloride injection
Page 75: Article link: http://www.ashp.org/D
Page 79: • Covis purchased all rights to F
show all

April 2012 Drug Information Update - Pharmacy Benefits ...

Create successful ePaper yourself

Delete template?

Save as template?